Sinovac Biotech logo

SVA - Sinovac Biotech News Story

$6.47 0.0  0.0%

Last Trade - 22/02/19

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £189.2m
Position in Universe th / 6858

BRIEF-Sinovac Reports Q4 EPS $0.96

Fri 23rd April, 2021 12:05am
April 22 (Reuters) - Sinovac Biotech Ltd  SVA.O :
    * SINOVAC REPORTS UNAUDITED FOURTH QUARTER 2020 FINANCIAL
RESULTS
AND FILES 2020 ANNUAL REPORT ON FORM 20-F
    * Q4 NON-GAAP EARNINGS PER SHARE $1.02
    * Q4 EARNINGS PER SHARE $0.96
    * Q4 SALES $327.5 MILLION VERSUS $81.1 MILLION

Source text for Eikon:  ID:nBw1HcJYka 
Further company coverage:  SVA.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.